2024-05-01 |
2024-04-29 |
VP
Vente planifiée
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
1 000
-2.2%
6,40
100 000
USD
|
1 000
-2.2%
|
6,40
|
100 000
USD
|
|
2024-04-17 |
2024-04-15 |
VP
Vente planifiée
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
7 500
-0.6%
7,06
52 924
USD
|
7 500
-0.6%
|
7,06
|
52 924
USD
|
|
2024-04-02 |
2024-04-01 |
VP
Vente planifiée
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
1 518
-0.1%
7,31
11 097
USD
|
1 518
-0.1%
|
7,31
|
11 097
USD
|
|
2024-03-22 |
2024-03-20 |
VP
Vente planifiée
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
86 000
-21.6%
7,73
664 978
USD
|
86 000
-21.6%
|
7,73
|
664 978
USD
|
|
2024-02-28 |
2024-02-26 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
5 183
-2.9%
9,20
47 684
USD
|
5 183
-2.9%
|
9,20
|
47 684
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Felsch Robert Ora
See Remarks
Dirigeant
|
2 352
-1.3%
8,75
20 571
USD
|
2 352
-1.3%
|
8,75
|
20 571
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
2 294
-1.3%
8,75
20 064
USD
|
2 294
-1.3%
|
8,75
|
20 064
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
5 017
-1.3%
8,75
43 880
USD
|
5 017
-1.3%
|
8,75
|
43 880
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
4 432
-1.1%
8,75
38 764
USD
|
4 432
-1.1%
|
8,75
|
38 764
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
5 341
-1.7%
8,75
46 714
USD
|
5 341
-1.7%
|
8,75
|
46 714
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Blanks Robert
See Remarks
Dirigeant
|
5 017
-1.3%
8,75
43 880
USD
|
5 017
-1.3%
|
8,75
|
43 880
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
4 803
-1.2%
8,75
42 008
USD
|
4 803
-1.2%
|
8,75
|
42 008
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
6 928
-1.5%
8,75
60 594
USD
|
6 928
-1.5%
|
8,75
|
60 594
USD
|
|
2024-02-22 |
2024-02-20 |
V
Vente
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
22 917
-1.7%
8,75
200 439
USD
|
22 917
-1.7%
|
8,75
|
200 439
USD
|
|
2024-02-09 |
2024-02-08 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
15 344
-3.8%
9,18
140 846
USD
|
15 344
-3.8%
|
9,18
|
140 846
USD
|
|
2024-01-10 |
2024-01-08 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
30 000
-9.5%
6,64
199 200
USD
|
30 000
-9.5%
|
6,64
|
199 200
USD
|
|
2023-12-28 |
2023-12-26 |
VP
Vente planifiée
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
225 000
-55.2%
6,36
1 430 123
USD
|
225 000
-55.2%
|
6,36
|
1 430 123
USD
|
|
2023-12-20 |
2023-12-18 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
5 675
-1.8%
6,07
34 447
USD
|
5 675
-1.8%
|
6,07
|
34 447
USD
|
|
2023-12-15 |
2023-12-14 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
7 000
-2.1%
5,55
38 850
USD
|
7 000
-2.1%
|
5,55
|
38 850
USD
|
|
2023-12-13 |
2023-12-11 |
VP
Vente planifiée
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
50 000
-15.4%
5,08
253 925
USD
|
50 000
-15.4%
|
5,08
|
253 925
USD
|
|
2023-12-08 |
2023-12-08 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
20 000
-5.7%
5,27
105 476
USD
|
20 000
-5.7%
|
5,27
|
105 476
USD
|
|
2023-12-06 |
2023-12-05 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
10 272
-2.9%
5,00
51 360
USD
|
10 272
-2.9%
|
5,00
|
51 360
USD
|
|
2023-12-01 |
2023-11-30 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
3 000
-0.8%
4,50
13 500
USD
|
3 000
-0.8%
|
4,50
|
13 500
USD
|
|
2023-11-22 |
2023-11-20 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
932
-0.8%
4,36
4 066
USD
|
932
-0.8%
|
4,36
|
4 066
USD
|
|
2023-11-22 |
2023-11-20 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
2 835
-0.8%
4,36
12 367
USD
|
2 835
-0.8%
|
4,36
|
12 367
USD
|
|
2023-11-22 |
2023-11-20 |
VP
Vente planifiée
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
2 581
-1.0%
4,36
11 259
USD
|
2 581
-1.0%
|
4,36
|
11 259
USD
|
|
2023-11-22 |
2023-11-20 |
VP
Vente planifiée
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
2 873
-0.9%
4,36
12 533
USD
|
2 873
-0.9%
|
4,36
|
12 533
USD
|
|
2023-11-22 |
2023-11-20 |
V
Vente
|
Blanks Robert
See Remarks
Dirigeant
|
2 835
-1.1%
4,36
12 367
USD
|
2 835
-1.1%
|
4,36
|
12 367
USD
|
|
2023-11-22 |
2023-11-20 |
VP
Vente planifiée
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
4 714
-1.3%
4,36
20 563
USD
|
4 714
-1.3%
|
4,36
|
20 563
USD
|
|
2023-11-22 |
2023-11-20 |
VP
Vente planifiée
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
11 368
-1.3%
4,36
49 589
USD
|
11 368
-1.3%
|
4,36
|
49 589
USD
|
|
2023-11-22 |
2023-11-20 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
2 384
-0.7%
4,36
10 399
USD
|
2 384
-0.7%
|
4,36
|
10 399
USD
|
|
2023-11-22 |
2023-11-20 |
VP
Vente planifiée
|
Felsch Robert Ora
See Remarks
Dirigeant
|
1 044
-0.9%
4,36
4 554
USD
|
1 044
-0.9%
|
4,36
|
4 554
USD
|
|
2023-11-17 |
2023-11-15 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
25 000
-8.6%
4,00
99 998
USD
|
25 000
-8.6%
|
4,00
|
99 998
USD
|
|
2023-10-12 |
2023-10-10 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
1 644
-0.4%
4,00
6 576
USD
|
1 644
-0.4%
|
4,00
|
6 576
USD
|
|
2023-09-12 |
2023-09-08 |
VP
Vente planifiée
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
2 897
-0.8%
4,55
13 181
USD
|
2 897
-0.8%
|
4,55
|
13 181
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
937
-0.8%
3,55
3 328
USD
|
937
-0.8%
|
3,55
|
3 328
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
2 846
-0.8%
3,55
10 108
USD
|
2 846
-0.8%
|
3,55
|
10 108
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Blanks Robert
See Remarks
Dirigeant
|
2 846
-1.1%
3,55
10 108
USD
|
2 846
-1.1%
|
3,55
|
10 108
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Felsch Robert Ora
See Remarks
Dirigeant
|
1 048
-0.9%
3,55
3 722
USD
|
1 048
-0.9%
|
3,55
|
3 722
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
2 884
-0.9%
3,55
10 243
USD
|
2 884
-0.9%
|
3,55
|
10 243
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
2 392
-0.7%
3,55
8 496
USD
|
2 392
-0.7%
|
3,55
|
8 496
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
11 419
-1.3%
3,55
40 558
USD
|
11 419
-1.3%
|
3,55
|
40 558
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
4 733
-1.3%
3,55
16 811
USD
|
4 733
-1.3%
|
3,55
|
16 811
USD
|
|
2023-08-23 |
2023-08-21 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
2 591
-0.9%
3,55
9 203
USD
|
2 591
-0.9%
|
3,55
|
9 203
USD
|
|
2023-06-29 |
2023-06-27 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
25 000
-7.8%
3,35
83 633
USD
|
25 000
-7.8%
|
3,35
|
83 633
USD
|
|
2023-06-27 |
2023-06-23 |
VP
Vente planifiée
|
Blanks Robert
See Remarks
Dirigeant
|
33 333
-11.1%
3,63
121 042
USD
|
33 333
-11.1%
|
3,63
|
121 042
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
2 873
-0.8%
3,65
10 496
USD
|
2 873
-0.8%
|
3,65
|
10 496
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
4 711
-1.3%
3,65
17 210
USD
|
4 711
-1.3%
|
3,65
|
17 210
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
2 583
-0.8%
3,65
9 436
USD
|
2 583
-0.8%
|
3,65
|
9 436
USD
|
|
2023-05-25 |
2023-05-23 |
V
Vente
|
Blanks Robert
See Remarks
Dirigeant
|
2 835
-1.1%
3,65
10 357
USD
|
2 835
-1.1%
|
3,65
|
10 357
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
Felsch Robert Ora
See Remarks
Dirigeant
|
1 046
-0.9%
3,65
3 821
USD
|
1 046
-0.9%
|
3,65
|
3 821
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
11 357
-1.3%
3,65
41 489
USD
|
11 357
-1.3%
|
3,65
|
41 489
USD
|
|
2023-05-25 |
2023-05-23 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
934
-0.8%
3,65
3 412
USD
|
934
-0.8%
|
3,65
|
3 412
USD
|
|
2023-05-25 |
2023-05-23 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
2 835
-0.8%
3,65
10 357
USD
|
2 835
-0.8%
|
3,65
|
10 357
USD
|
|
2023-05-25 |
2023-05-23 |
VP
Vente planifiée
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
2 384
-0.7%
3,65
8 709
USD
|
2 384
-0.7%
|
3,65
|
8 709
USD
|
|
2023-03-02 |
2023-02-21 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
5 586
-1.5%
3,00
16 764
USD
|
5 586
-1.5%
|
3,00
|
16 764
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
RAAB MICHAEL
President & CEO
Administrateur exécutif
|
13 449
-1.5%
3,00
40 360
USD
|
13 449
-1.5%
|
3,00
|
40 360
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Felsch Robert Ora
See Remarks
Dirigeant
|
3 214
-2.7%
3,00
9 645
USD
|
3 214
-2.7%
|
3,00
|
9 645
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
1 114
-1.0%
3,00
3 343
USD
|
1 114
-1.0%
|
3,00
|
3 343
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Rosenbaum David P.
Chief Development Officer
Dirigeant
|
3 394
-0.9%
3,00
10 185
USD
|
3 394
-0.9%
|
3,00
|
10 185
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
3 439
-1.0%
3,00
10 320
USD
|
3 439
-1.0%
|
3,00
|
10 320
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Blanks Robert
See Remarks
Dirigeant
|
3 394
-1.2%
3,00
10 185
USD
|
3 394
-1.2%
|
3,00
|
10 185
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
3 187
-1.0%
3,00
9 564
USD
|
3 187
-1.0%
|
3,00
|
9 564
USD
|
|
2023-02-24 |
2023-02-21 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
2 914
-0.9%
3,00
8 745
USD
|
2 914
-0.9%
|
3,00
|
8 745
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
1 193
-0.5%
1,95
2 326
USD
|
1 193
-0.5%
|
1,95
|
2 326
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
33
-0.0%
1,95
64
USD
|
33
-0.0%
|
1,95
|
64
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Williams Laura A
Chief Medical Officer
Dirigeant
|
15
-0.0%
1,94
29
USD
|
15
-0.0%
|
1,94
|
29
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
3 303
-1.2%
1,95
6 439
USD
|
3 303
-1.2%
|
1,95
|
6 439
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
22
-0.0%
1,95
43
USD
|
22
-0.0%
|
1,95
|
43
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Rodriguez Susan
Chief Commercial Officer
Dirigeant
|
131
-0.0%
1,94
254
USD
|
131
-0.0%
|
1,94
|
254
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
1 193
-0.5%
1,95
2 326
USD
|
1 193
-0.5%
|
1,95
|
2 326
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
20
-0.0%
1,95
39
USD
|
20
-0.0%
|
1,95
|
39
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
GRAMMER ELIZABETH A
See Remarks
Dirigeant
|
29
-0.0%
1,94
56
USD
|
29
-0.0%
|
1,94
|
56
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
1 443
-0.5%
1,95
2 813
USD
|
1 443
-0.5%
|
1,95
|
2 813
USD
|
|
2022-11-23 |
2022-11-22 |
V
Vente
|
Renz Justin A
Chief Financial Officer
Dirigeant
|
61
-0.0%
1,94
118
USD
|
61
-0.0%
|
1,94
|
118
USD
|
|